abstract |
A novel pyrimidine derivative, or pharmaceutically acceptable salt thereof, fused with a nonaromatic ring selected from among dihydrothiophene, dihydrofuran, a cycloalkyl, etc.; and a pharmaceutical composition comprising any of the above compounds as an active ingredient. These compounds exhibit excellent insulin secretion accelerating action and hyperglycemic action. Therefore, pharmaceutical compositions comprising the above compounds as an active ingredient due to the action thereof are useful in the therapy and/or prevention of insulin-dependent diabetes mellitus (type 1 diabetes), insulin-independent diabetes mellitus (type 2 diabetes), insulin resistant diseases, obesity, etc. |